Skip to main content
. 2010 Oct 25;11:246. doi: 10.1186/1471-2474-11-246

Table 1.

Patient characteristics among groups

Characteristics Etoricoxib Celecoxib Placebo P-value
· Number 35 35 32
· Sex: Male (%) 33 (94.29) 31 (88.57) 28 (87.50) 0.375
· Mean duration of injury (SD) 18.22 (15.93) 28.31 (44.87) 35.41 (49.23) 0.477
· Associated injury 0.234
 None 9 (25.71) 7 (20.00) 9 (28.13)
 Medial meniscus 16 (45.71) 17 (48.57) 10 (31.25)
 Lateral meniscus 5 (14.30) 7 (20.00) 6 (18.75)
 Both meniscus 2 (5.71) 1 (2.86) 7 (21.88)
 Articular injury 2 (5.71) 2 (5.71) 0 (0)
 Both meniscus and articular injury 1 (2.86) 1 (2.86) 0 (0)
· Concomitant surgery 0.75
 None 13 (37.15) 13 (37.14) 13 (40.63)
 Medial menisectomy 13 (37.15) 11 (31.43) 10 (31.25)
 Lateral menisectomy 3 (5.87) 5 (14.29) 6 (18.75)
 Both medial and lateral menisectomy 2 (5.71) 0 (0) 2 (6.06)
 Cartilage debridement 2 (5.71) 5 (14.29) 2 (6.25)
· Mean pain score before surgery (SD) 11.17 (17.76) 14.0 (21.58) 15.62 (26.39) 0.721
· Mean operative time (SD) 52.50 (10.76) 60.73 (14.20) 60.45 (20.30) 0.223
· Mean tourniquet time (SD) 56.08 (9.69) 63.25 (12.84) 63.90 (19.33) 0.089
· Mean drain output at 24 hr./ml (SD) 170.77 (183.68) 218.94(231.48) 143.28(106.40) 0.663